Gender-specific relationship between prenatal exposure to phthalates and intrauterine growth restriction

Yan Zhao1, Li Chen1, Lu-Xi Li1

  • 1Department of Environmental Health, School of Public Health, Fudan University, Shanghai, China.

Pediatric Research
|July 9, 2014
PubMed

Insights

Prenatal phthalate exposure is linked to a higher risk of intrauterine growth retardation (IUGR), especially in male newborns. Higher phthalate metabolite levels in mothers correlated with reduced fetal growth.

Area of Science:

  • Environmental Health
  • Reproductive Toxicology
  • Perinatal Medicine

Background:

  • No prior studies have investigated the link between prenatal phthalate exposure and intrauterine growth retardation (IUGR).
  • This research addresses the knowledge gap concerning phthalate exposure during pregnancy and its impact on fetal development.

Purpose of the Study:

  • To determine the association between prenatal phthalate exposure and the risk of developing IUGR.
  • To explore potential sex-specific differences in susceptibility to phthalate exposure regarding fetal growth.

Main Methods:

  • A case-control study involving 126 mother-newborn pairs (42 IUGR cases, 84 controls).
  • Maternal urine samples collected in the third trimester analyzed for five phthalate metabolites.
  • Phthalate metabolite concentrations were quantified using established laboratory techniques.

Main Results:

  • Elevated levels of monomethyl phthalate (MMP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and SumDEHP were found in IUGR cases.
  • Higher MEHHP and MEOHP concentrations were inversely associated with fetal growth indicators (birth weight, Quetelet's index) in the overall cohort.
  • A significant exposure-response relationship was observed between MEHHP/SumDEHP and IUGR; male infants showed greater sensitivity to phthalate exposure than females.

Conclusions:

  • Prenatal phthalate exposure is associated with an increased risk of intrauterine growth retardation.
  • Male newborns appear more vulnerable to the adverse effects of phthalate exposure on fetal growth compared to females.
  • Findings highlight the importance of monitoring and reducing phthalate exposure during pregnancy to improve perinatal outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K